Philman's Pharm: "German Quality, California Ingenuity." Est. 1977

In a telephone conversation with the Dutch health Minister Hugo de Jonge, the German counterpart and CDU politician Jens Spahn is said to have acted to ensure that the supply bottlenecks in the field of marijuana…

Because cannabis patients are not allowed to grow their own natural medicine in the garden or in tents, health insurance companies, pharmacies and importers need to work closely together so that the prescribed medicine is actually available when needed. However, as the need for the nearly side-effect free medicinal plant is much greater than originally expected from cannabis for medical-releasing government, the costly imports of medicinal hemp are in no way sufficient for the ever-growing patient base. In order for the delayed future of cannabis cultivation in Germany not to affect other sick people, the government has now acted and requested twice the amount of grass from the Netherlands.


In a telephone conversation with the Dutch health Minister Hugo de Jonge, the German counterpart and CDU politician Jens Spahn is said to have acted to ensure that the supply bottlenecks in the field of marijuana are not quite as strong. Of the originally planned 700 kilograms of Dutch medicinal hemps, more than twice the amount has been increased, so now thanks to the commitment of Hugo de Jonge with an amount of up to 1500 kilos of marijuana in German pharmacies calculated annuallycan be. The 1.5 tons are needed because a mistake in the bidding process of the BfArM cannabis agency ensured that it was not possible in court to distribute licenses for the cultivation of cannabis in a timely manner. Because it is not until 2020 at the earliest in the harvest of marijuana produced in this country can be expected, the federal government must increase the import quantities of coveted medicine accordingly . Federal Minister of Health Jens Spahn called the verbally closed trade a ” lived neighborhood ” and emphasized that the Netherlands “made an important contribution to the medical treatment of German patients “.


Why in the neighboring country, however , enjoyment consumption for decades no major problem for public life and why from the moment of acquiescence no bottlenecks more emerge in the supply routes in the medical sector , the CDU politician but would rather not from his Dutch counterpart in conversation explain. As far as the friendship goes then apparently not again – and you pay eventually also voluntarily with cash for their own inability; but certainly not for teachings.



Author: Cenedella.de

Over the last 4 decades I have been involved in the fight for patient rights in America, and now here in Germany. During my career I have served as a Board of Director for the World Trade Center San Diego and as a Lead Consultant for Deutsche Telekom's Executive Board, Co-Founded the San Diego Software Council and the Dayton Human Trafficking Accords and was Director of LawInfo's Lead Council Program. Previously I was a C-Level Business Development Executive in the technology sector, but also involved with the cannabis industry since 1977. More recently I have been fulltime in the legal medical marijuana industry here in Europe, helping international companies navigate the biggest potential market in the world. This website is light on details due to confidentiality issues with clients but be rest assured I am knowledgeable, professional and with street cred in the industry that can immediately assist your growth in some way. Consulting Services: Sales and Business Development Assist with Strategic Direction Professionally represent your firm Special Projects management Licensing and compliance Sales and Distribution networks Qualify potential partners I am your resource on the ground in Europe, contact me directly to schedule an initial discussion on the German Cannabis-as-Medicine market. Thank you, Philip J. Cenedella IV Call +1.888.206.3264 USA + GERMANY Skype: philip.j.cenedella eMail: phil@cenedella.de LinkedIN: https://www.linkedin.com/in/cenedellade/

Comments are closed.